Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. [electronic resource]
Producer: 20080819Description: 1448-58 p. digitalISSN:- 1460-2180
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- MAP Kinase Kinase 1 -- biosynthesis
- MAP Kinase Signaling System
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Mitomycin -- administration & dosage
- Phosphorylation
- Proteasome Endopeptidase Complex -- metabolism
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- RNA, Messenger -- biosynthesis
- Rad51 Recombinase -- biosynthesis
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.